ClinicalTrialsFinder

Recurrent Ovarian Serous Adenocarcinoma Clinical Trials in Buffalo, New York

1 recruitingBuffalo, New York

Showing 1–1 of 1 trials

Recruiting
Phase 2

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Platinum-Sensitive Ovarian CarcinomaRecurrent Ovarian CarcinomaRecurrent Fallopian Tube Carcinoma+12 more
Roswell Park Cancer Institute80 enrolled2 locationsNCT05231122